Recent
Chromatin optimizes sorghum - Biomass Magazine Article
Biomass Magazine reporter Lisa Gibson describes how Chromatin Inc. will use its expanding technology portfolio to optimize fit-for-purpose sorghum for use in biofuels, biopower and renewable chemicals.Read more
Chromatin’s co-founders Daphne Preuss (CEO) and Gregory P. Copenhaver profile an exciting new technology.
The technology was developed by Simon Chan and his colleague Maruthachalam Ravi at the University of California Davis and was published in the March issue of Nature (2010, 464: 615-618).Read more
ACGT and Chromatin, Inc. Announce Agreement to Pursue Technology Partnership | May 5th, 2010
CHICAGO, IL - May 5, 2010 - ACGT Sdn Bhd ("ACGT") and Chromatin, Inc. jointly announce their intent to pursue a long term research agreement to develop mini-chromosome technology. Earlier today, Derrik Khoo Sin Huat, CEO of ACGT, a wholly-owned subsidiary of Genting Plantations Berhad, and Dr. Daphne Preuss, CEO of Chromatin, signed a Memorandum of Understanding to solidify the intent of both companies, at a ceremony witnessed by Yang Berhormat Datuk Seri Dr. Maximus Johnity Ongkili, Minister of Science, Technology and Innovation Malaysia (MOSTI). This notable event took place in conjunction with the BIO International Convention taking place in Chicago, a biotechnology conference attended by industry leaders and dignitaries from all over the world.Read more
Chromatin, Inc. to Address Business, Technology Implications of Plant Science at International BIO Convention | May 4th, 2010
Chromatin, Inc. announced today that CEO Daphne Preuss and Director of Transgenic Programs Otto Folkerts will speak on the business and technology implications of the company's work in separate panels at the BIO International Convention 2010, occurring this week at McCormick Place in Chicago, IL. The international convention, hosted by the Biotechnology Industry Organization (BIO), is the largest global event for the biotechnology industry.Read more
Chromatin, Inc. Announces Commitment to Optimize Sorghum as a Feedstock for Renewables Market Applications | April 28th, 2010
Speaking today at the Advanced Biofuels Leadership Conference in Washington, D.C., Chromatin, Inc. CEO Daphne Preuss will announce that the company is expanding its technology development portfolio to produce fit-for-purpose sorghum as a renewable feedstock for the biofuels, green power and renewable chemicals sectors.Read more
Chromatin, Inc. Acquires Sorghum Partners, Inc. (SPI) and Milo Genetics, LP | April 28th, 2010
Today, Chromatin, Inc. announces that the company has acquired the assets of Sorghum Partners, Inc. (SPI) and Milo Genetics, LP. The transaction provides Chromatin with access to SPI's well-established multi-national network of sorghum growers and distributors as well as existing sorghum seed production facilities, representing over 7% of the sorghum hybrid market in the US. The deal also provides Chromatin with commercially viable germplasm from Milo Genetics, which is underpinned by decades of experience in providing quality products to the market. The integration of SPI and Milo Genetics further accelerates Chromatin's efforts to commercialize a portfolio of proprietary sorghum lines as bioenergy feedstocks.Read more
Chromatin Inc. Recruits Industry R&D Leader David Jessen as its Chief Technology Officer | April 1st, 2010
Effective today, Chromatin, Inc. announces the appointment of biotechnology and trait development expert David L. Jessen, Ph.D as the company's Chief Technology Officer. Jessen will oversee all facets of Chromatin's continued commercialization of its mini-chromosome gene-stacking technologies as well as lead the company's efforts to develop a portfolio of high-value biomass feedstocks targeted at the bioenergy sector.Read more
Research Park Biotech Firm Chromatin, Inc. Expands Operations at University of Illinois | March 29th, 2010
The University of Illinois today announces that Chromatin, Inc., a biotechnology company that has occupied space in the University's Research Park since 2005 as part of the EnterpriseWorks incubator, is expanding operations and graduating to a 5,000 square foot facility in the Research Park. The expansion marks the company's continued significant progress in commercializing its proprietary technology, including mini-chromosomes which were originally developed at the University of Chicago by company co-founder and CEO Daphne Preuss.Read more
Biotech and Agribusiness Leader Joins Chromatin, Inc. Board of Directors | March 25th, 2010
Today, Chromatin, Inc. announced the appointment of Dr. John A. Greaves, Ph.D., Worldwide Director, Specialty Crop Improvement at Kemin Industries, Inc., to the company's Board of Directors. The addition of Dr. Greaves will allow Chromatin to gain significant insight from his leadership in crop development and biotechnology operations, as the company readies itself for the production of products supporting the energy feedstock sector.Read more
Dow AgroSciences, Chromatin Announce Research, License Agreements | November 11th, 2009
Dow AgroSciences LLC, a wholly owned subsidiary of The Dow Chemical Company, and Chromatin Inc. announced today that the companies have entered into two agreements: the first provides Dow with rights to Chromatin's Mini-Chromosome technology and the second establishes an exclusive research and license agreement to combine EXZACT™ Precision Technology with Mini-Chromosomes, creating a novel technology platform for the development of next generation traits in corn, soybeans and canola.Read more
Chromatin, Inc. adds two to executive team | September 24th, 2009
Chromatin, Inc. announced today two additions to its executive team. Ken Davenport will serve as the Vice President of Strategic Development and Jeff Scheib will serve as the Vice President of Biofuels.Read more
Chromatin and Bayer CropScience launch mini-chromosome technology alliance | August 20th, 2009
Chromatin Inc. and Bayer CropScience announced today that they have entered into a technological alliance and license agreement to use Chromatin's proprietary mini-chromosome technology for crop improvement. Read more
Chromatin Licenses Gene Stacking Technology for Sugar cane to Syngenta | June 26th, 2009
Chromatin Inc. announced today that it has entered into an exclusive worldwide research and commercial license agreement with Syngenta Biotechnology Inc. for Chromatin's proprietary gene stacking technology in sugar cane. Read more
Daphne Preuss elected to serve on BIO's Board of Directors | May 20th, 2009
Chromatin CEO Daphne Preuss has been elected to serve on the Biotechnology Industry Organization's (BIO) Food & Agriculture Section Governing Board. Read more